Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,996,358 | 2,266,324 | 1,566,950 | 1,486,562 | 2,505,950 |
Marketable Securities | 947,462 | 700,641 | 578,707 | 874,095 | 765,160 |
Receivables | 2,347,315 | 2,324,991 | 2,431,296 | 2,365,417 | 1,747,320 |
Inventories | 1,649,030 | 1,582,493 | 1,629,677 | 1,682,960 | 1,763,020 |
Other current assets | 2 | 1 | 0 | 0 | 618,100 |
TOTAL | $6,940,167 | $6,874,450 | $6,206,630 | $6,409,034 | $7,399,550 |
Non-Current Assets | |||||
PPE Net | 3,721,939 | 3,584,396 | 3,643,488 | 3,654,875 | N/A |
Investments And Advances | 39,398 | 43,874 | 41,645 | 53,419 | 7,280 |
Intangibles | 258,336 | 247,443 | 250,387 | 259,161 | 0 |
Other Non-Current Assets | 387,764 | 448,659 | 394,848 | 414,834 | 773,190 |
TOTAL | $4,407,437 | $4,324,372 | $4,330,368 | $4,382,289 | $780,470 |
Total Assets | $11,347,600 | $11,198,820 | $10,537,000 | $10,791,320 | $12,092,050 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 86,400 | 98,843 | 67,046 | 67,523 | 65,600 |
Accounts payable and accrued liabilities | 666,835 | 452,021 | 456,538 | 451,328 | 615,080 |
Accrued Expenses | N/A | N/A | N/A | N/A | 218,850 |
Other current liabilities | 2,883,341 | 2,956,879 | 3,167,597 | 2,929,225 | 2,984,040 |
TOTAL | $3,739,046 | $4,408,591 | $4,121,798 | $3,877,366 | $3,883,590 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 84,554 | 86,746 | 90,089 | 93,820 |
Other Non-Current Liabilities | 460,858 | 404,617 | 428,717 | 452,915 | 516,400 |
TOTAL | $587,347 | $795,785 | $1,000,685 | $1,209,242 | $1,209,420 |
Total Liabilities | $4,326,394 | $5,204,376 | $5,122,483 | $5,086,607 | $5,093,020 |
Shareholders' Equity | |||||
Common Shares | 96,768 | 94,136 | 96,768 | 102,254 | 108,400 |
Retained earnings | 6,739,373 | 5,817,437 | 5,328,979 | 5,515,898 | 6,936,040 |
Other shareholders' equity | 188,068 | 85,873 | -9,232 | 91,563 | -41,410 |
TOTAL | $7,021,209 | $5,994,446 | $5,414,515 | $5,704,715 | $6,999,030 |
Total Liabilities And Equity | $11,347,603 | $11,198,822 | $10,536,998 | $10,791,322 | $12,092,050 |